journal article·2026-05-10Open access

HNRNPD Induces Radioresistance in Nasopharyngeal Carcinoma by Sequestering GRAMD4 mRNA in Stress Granules

Yingzi Li, Tong Xiang, Yuanyuan Liu, Desheng Weng, Jingjing Zhao, Hao Chen, Yan Tang, Songzuo Xie, Hao Zhang, Jun Luo, Xinyi Yang, Qiuzhong Pan, Muping Di, Jianchuan Xia

Abstract

ABSTRACT Radiotherapy resistance remains a major obstacle in nasopharyngeal carcinoma (NPC). Stress granules (SGs), dynamic cytoplasmic ribonucleoprotein condensates, have been linked to therapy resistance, but their role in NPC radioresistance remains unclear. Here, we show that SGs are key mediators of NPC radioresistance. Radioresistant NPC cells displayed markedly enhanced SG formation in a dose‐ and time‐dependent manner, whereas pharmacological inhibition with ISRIB or genetic disruption of G3BP1 significantly sensitized cells to irradiation in vitro and in vivo. Integrated transcriptomic and proteomic analyses identified heterogeneous nuclear ribonucleoprotein D (HNRNPD) as a critical SG‐associated RNA‐binding protein upregulated in resistant cells and associated with poor prognosis. Functionally, HNRNPD promoted radioresistance by suppressing apoptosis, whereas its depletion restored radiosensitivity. Mechanistically, HNRNPD underwent RNA‐dependent phase separation through its C‐terminal intrinsically disordered region and interacted with G3BP1 to facilitate SG assembly. Irradiation promoted cytoplasmic accumulation of HNRNPD, while the p37 isoform preferentially bound G3BP1 and functionally drove SG formation. HNRNPD further bound GRAMD4 mRNA via its RRM1 domain and sequestered it in SG‐associated compartments, thereby repressing GRAMD4 translation, suppressing mitochondrial apoptosis, and promoting survival. Restoration of GRAMD4 abrogated HNRNPD‐induced radioresistance. Together, these findings establish the HNRNPD–SG–GRAMD4 axis as a key determinant of NPC radioresistance and a potential therapeutic target for radiosensitization.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Research and Splicing · Nuclear Structure and Function · Signaling Pathways in Disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou China

Department of Biotherapy Sun Yat‐sen University Cancer Center Guangzhou China

Department of Experimental Research Sun Yat‐sen University Cancer Center Guangzhou Guangdong China

Department of Medical Oncology The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

Department of Nuclear Medicine Sun Yat‐sen University Cancer Center Guangzhou China

Department of Radiation Oncology Nanfang Hospital Southern Medical University Guangzhou China

Funding

National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.1001/jamanetworkopen.2022.017310.1001/jamanetworkopen.2022.0173 ↗
2. 10.1016/S0140‐6736(15)00055‐010.1016/S0140‐6736(15)00055‐0 ↗
3. 10.1038/s41588‐025‐02253‐810.1038/s41588‐025‐02253‐8 ↗
4. 10.1016/j.ijrobp.2019.03.04310.1016/j.ijrobp.2019.03.043 ↗
5. 10.1016/S0140‐6736(23)00269‐610.1016/S0140‐6736(23)00269‐6 ↗
6. 10.1016/j.cell.2020.03.04610.1016/j.cell.2020.03.046 ↗
7. 10.1016/j.cell.2023.05.04710.1016/j.cell.2023.05.047 ↗
8. 10.1016/j.canlet.2023.21630510.1016/j.canlet.2023.216305 ↗
9. 10.1016/j.canlet.2023.21642010.1016/j.canlet.2023.216420 ↗
10. 10.1038/s41467‐025‐62417‐210.1038/s41467‐025‐62417‐2 ↗
11. 10.1038/s41467‐025‐62619‐810.1038/s41467‐025‐62619‐8 ↗
12. 10.1093/nar/gkab08010.1093/nar/gkab080 ↗
13. 10.1016/j.cell.2015.07.04710.1016/j.cell.2015.07.047 ↗
14. 10.1038/nature1192210.1038/nature11922 ↗
15. Heterogeneous Nuclear Ribonucleoprotein K Is Overexpressed and Contributes to Radioresistance Irrespective of HPV Status in Head and Neck Squamous Cell Carcinoma [J]
16. 10.7150/ijbs.4124610.7150/ijbs.41246 ↗
17. 10.1073/pnas.181576711610.1073/pnas.1815767116 ↗
18. 10.1016/j.cell.2022.12.04610.1016/j.cell.2022.12.046 ↗
19. 10.1038/s41589‐020‐0524‐y10.1038/s41589‐020‐0524‐y ↗
20. 10.1038/s42255‐025‐01291‐010.1038/s42255‐025‐01291‐0 ↗
21. 10.1016/j.cell.2017.12.03210.1016/j.cell.2017.12.032 ↗
22. 10.1016/j.tcb.2016.05.00410.1016/j.tcb.2016.05.004 ↗
23. 10.1016/j.molcel.2024.11.01210.1016/j.molcel.2024.11.012 ↗
24. 10.1016/j.cell.2023.09.00610.1016/j.cell.2023.09.006 ↗
25. 10.1128/mcb.13.12.7652-7665.199310.1128/mcb.13.12.7652-7665.1993 ↗
26. 10.1038/s41467‐025‐60920‐010.1038/s41467‐025‐60920‐0 ↗
27. 10.1038/cdd.2010.15310.1038/cdd.2010.153 ↗
28. 10.1038/s43018‐025‐00984‐510.1038/s43018‐025‐00984‐5 ↗
29. 10.1038/s42003‐025‐08584‐w10.1038/s42003‐025‐08584‐w ↗
30. 10.1158/2159‐8290.CD‐21‐167210.1158/2159‐8290.CD‐21‐1672 ↗
31. 10.1002/advs.20240326210.1002/advs.202403262 ↗
32. 10.1261/rna.230810610.1261/rna.2308106 ↗
33. 10.1093/nar/gkr123810.1093/nar/gkr1238 ↗
34. 10.1083/jcb.147.7.143110.1083/jcb.147.7.1431 ↗
35. 10.1016/j.ijrobp.2023.08.04510.1016/j.ijrobp.2023.08.045 ↗
36. 10.7554/eLife.1841310.7554/eLife.18413 ↗
37. 10.1093/nar/gki101210.1093/nar/gki1012 ↗
38. 10.1038/ncomms624810.1038/ncomms6248 ↗
39. 10.1016/j.addr.2022.11456910.1016/j.addr.2022.114569 ↗
40. 10.1002/advs.20240316110.1002/advs.202403161 ↗
41. 10.1186/s12964‐025‐02372‐z10.1186/s12964‐025‐02372‐z ↗
42. 10.1038/s41583‐024‐00859‐110.1038/s41583‐024‐00859‐1 ↗
43. 10.1038/s41556‐024‐01418‐710.1038/s41556‐024‐01418‐7 ↗